Innoveren Scientific Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 2

Employees

  • Stock Symbol
  • IVRN

Stock Symbol

  • Investments
  • 4

Innoveren Scientific General Information

Description

Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.

Contact Information

Website
www.hcyte.com
Formerly Known As
H-CYTE, Inc., H-CYTE Incorporated, Spinez
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
PINX
Corporate Office
  • 2202 North West Shore Boulevard
  • Suite 200
  • Tampa, FL 33607
  • United States
+1 (404) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innoveren Scientific Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.02 $3.92K 713K 165K -$3.68

Innoveren Scientific Financials Summary

In Thousands,
USD
TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 6,352 5,578 12,164 29
Revenue 0 453 1,612 2,151
EBITDA (2,815) (10,425) (4,607) (4,915)
Net Income (3,259) (10,300) (4,799) (6,459)
Total Assets 789 137 321 2,204
Total Debt 4,438 3,923 3,618 1,173
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Innoveren Scientific Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Innoveren Scientific‘s full profile, request access.

Request a free trial

Innoveren Scientific Patents

Innoveren Scientific Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3407810-A1 Surgical tools for spinal facet therapy to alleviate pain Inactive 29-Jan-2016 000000000
EP-3190997-B8 Surgical tools with positional components Active 12-Dec-2014 00000000000
EP-3190997-B1 Surgical tools with positional components Active 12-Dec-2014 000000000
EP-3190997-A1 Surgical tools with positional components Active 12-Dec-2014 000000000
EP-3190997-A4 Surgical tools with positional components Active 12-Dec-2014 A61B17/8861 0
To view Innoveren Scientific’s complete patent history, request access »

Innoveren Scientific Executive Team (7)

Name Title Board Seat Contact Info
William Horne Chief Executive Officer & Chairman
Tanya Rhodes Ph.D Chief Scientific Officer & Interim Chief Executive Officer
Charlie Farrahar Chief Financial Officer
You’re viewing 3 of 7 executive team members. Get the full list »

Innoveren Scientific Board Members (4)

Name Representing Role Since
0000000 000000000 Self Chief Executive Officer 000 0000
0000000 0000000000 Innoveren Scientific Board Member 000 0000
0000000 00000 Innoveren Scientific Chief Executive Officer & Chairman 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Innoveren Scientific Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Innoveren Scientific Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Innoveren Scientific‘s full profile, request access.

Request a free trial

Innoveren Scientific Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SkinDisc 22-Dec-2022 0000000000 Other Healthcare Services 0000000 0
Jantibody 07-Sep-2022 0000000000 00.00 Other Healthcare 0000000 0
Regenerative Medicine Solutions (Pulmonary Biomedical Services and Patient Delivery Platform) 14-Jan-2019 0000000000 Outcome Management (Healthcare) 0000000 0
Streamline (Healthcare) 26-Mar-2015 Merger/Acquisition 00.00 Other Healthcare Technology Systems 0000000 0
To view Innoveren Scientific’s complete acquisitions history, request access »

Innoveren Scientific FAQs

  • When was Innoveren Scientific founded?

    Innoveren Scientific was founded in 2013.

  • Who is the founder of Innoveren Scientific?

    Steve Gorlin is the founder of Innoveren Scientific.

  • Who is the CEO of Innoveren Scientific?

    William Horne and Tanya Rhodes Ph.D are the CEOs of Innoveren Scientific.

  • Where is Innoveren Scientific headquartered?

    Innoveren Scientific is headquartered in Tampa, FL.

  • What is the size of Innoveren Scientific?

    Innoveren Scientific has 2 total employees.

  • What industry is Innoveren Scientific in?

    Innoveren Scientific’s primary industry is Drug Discovery.

  • Is Innoveren Scientific a private or public company?

    Innoveren Scientific is a Public company.

  • What is Innoveren Scientific’s stock symbol?

    The ticker symbol for Innoveren Scientific is IVRN.

  • What is the current market cap of Innoveren Scientific?

    The current market capitalization of Innoveren Scientific is $3.92K.

  • What is Innoveren Scientific’s annual earnings per share (EPS)?

    Innoveren Scientific’s EPS for 12 months was -$3.68.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »